1	[	[	O	(	O	10	DEP	-1
2	Treatment	Treatment	B-NP	NN	O	10	DEP	19	Treatment
3	of	of	B-PP	IN	O	2	NMOD	-1
4	the	the	B-NP	DT	O	6	NMOD	-1
5	diabetic	diabetic	I-NP	JJ	O	6	NMOD	-1
6	foot	foot	I-NP	NN	O	3	PMOD	-1
7	by	by	B-PP	IN	O	2	NMOD	-1
8	hyperbaric	hyperbaric	B-NP	JJ	O	9	NMOD	-1
9	oxygen	oxygen	I-NP	NN	O	7	PMOD	-1
10	]	]	O	)	O	0	ROOT	-1

1	Diabetic	Diabetic	B-NP	JJ	O	3	NMOD	-1
2	foot	foot	I-NP	NN	O	3	NMOD	-1
3	wounds	wound	I-NP	NNS	O	4	SUB	-1
4	are	be	B-VP	VBP	O	0	ROOT	-1
5	consequences	consequence	B-NP	NNS	O	15	NMOD	-1
6	of	of	B-PP	IN	O	5	NMOD	-1
7	the	the	B-NP	DT	O	8	NMOD	-1
8	neuropathy	neuropathy	I-NP	NN	O	6	PMOD	-1
9	and	and	O	CC	O	15	NMOD	-1
10	the	the	B-NP	DT	O	15	NMOD	-1
11	small	small	I-NP	JJ	O	15	NMOD	-1
12	and	and	I-NP	CC	O	15	NMOD	-1
13	large	large	I-NP	JJ	O	15	NMOD	-1
14	vessel	vessel	I-NP	NN	O	15	NMOD	-1
15	disease	disease	I-NP	NN	O	4	PRD	-1
16	that	that	B-NP	WDT	O	15	NMOD	-1
17	complicate	complicate	B-VP	VBP	O	16	SBAR	-1
18	diabetes	diabete	B-NP	NNS	O	17	OBJ	-1
19	.	.	O	.	O	4	P	-1

1	At	At	B-PP	IN	O	8	VMOD	-1
2	the	the	B-NP	DT	O	4	NMOD	-1
3	cellular	cellular	I-NP	JJ	O	4	NMOD	-1
4	level	level	I-NP	NN	O	1	PMOD	-1
5	,	,	O	,	O	8	P	-1
6	the	the	B-NP	DT	O	7	NMOD	-1
7	result	result	I-NP	NN	O	8	SUB	-1
8	is	be	B-VP	VBZ	O	0	ROOT	-1
9	hypoxia	hypoxia	B-NP	NN	O	8	PRD	-1
10	which	which	B-NP	WDT	O	9	NMOD	-1
11	impairs	impair	B-VP	VBZ	O	10	SBAR	0
12	wound	wound	B-NP	NN	O	13	NMOD	-1
13	healing	healing	I-NP	NN	O	11	OBJ	-1
14	.	.	O	.	O	8	P	-1

1	Hyperbaric	Hyperbaric	B-NP	JJ	O	2	NMOD	-1
2	oxygenation	oxygenation	I-NP	NN	O	6	SUB	-1
3	(	(	O	(	O	5	DEP	-1
4	HBO	HBO	B-NP	NN	B-protein	5	DEP	-1
5	)	)	O	)	O	2	NMOD	-1
6	may	may	B-VP	MD	O	0	ROOT	-1
7	be	be	I-VP	VB	O	6	VC	-1
8	a	a	B-NP	DT	O	10	NMOD	-1
9	useful	useful	I-NP	JJ	O	10	NMOD	-1
10	adjuvant	adjuvant	I-NP	NN	O	7	PRD	-1
11	to	to	B-VP	TO	O	12	VMOD	-1
12	wound	wound	I-VP	VB	O	10	NMOD	-1
13	care	care	B-NP	NN	O	12	OBJ	-1
14	.	.	O	.	O	6	P	-1

1	It	It	B-NP	PRP	O	2	SUB	-1
2	leads	lead	B-VP	VBZ	O	0	ROOT	0
3	to	to	B-PP	TO	O	2	VMOD	-1
4	enhanced	enhance	B-NP	VBN	O	5	NMOD	0
5	oxygenation	oxygenation	I-NP	NN	O	3	PMOD	-1
6	of	of	B-PP	IN	O	5	NMOD	-1
7	the	the	B-NP	DT	O	9	NMOD	-1
8	affected	affect	I-NP	VBN	O	9	NMOD	16	affected
9	tissues	tissue	I-NP	NNS	O	6	PMOD	-1
10	,	,	O	,	O	2	P	-1
11	has	have	B-VP	VBZ	O	2	VMOD	-1
12	an	an	B-NP	DT	O	14	NMOD	-1
13	antiseptic	antiseptic	I-NP	JJ	O	14	NMOD	-1
14	effect	effect	I-NP	NN	O	11	OBJ	0
15	,	,	O	,	O	2	P	-1
16	reduces	reduce	B-VP	VBZ	O	2	VMOD	18	reduces
17	edema	edema	B-NP	NN	O	16	OBJ	-1
18	,	,	O	,	O	2	P	-1
19	and	and	O	CC	O	2	VMOD	-1
20	accelerates	accelerate	B-VP	VBZ	O	2	VMOD	17	accelerates
21	collagen	collagen	B-NP	NN	B-protein	22	NMOD	-1
22	production	production	I-NP	NN	O	24	NMOD	9	production
23	and	and	I-NP	CC	O	24	NMOD	-1
24	angiogenesis	angiogenesis	I-NP	NN	O	20	OBJ	3	angiogenesis
25	,	,	O	,	O	2	P	-1
26	thus	thus	B-ADVP	RB	O	27	VMOD	-1
27	enhancing	enhance	B-VP	VBG	O	2	VMOD	17	enhancing
28	tissue	tissue	B-NP	NN	O	29	NMOD	-1
29	repair	repair	I-NP	NN	O	27	OBJ	2	repair
30	.	.	O	.	O	2	P	-1

1	14	14	B-NP	CD	O	2	NMOD	-1
2	diabetics	diabetic	I-NP	NNS	O	18	SUB	-1
3	with	with	B-PP	IN	O	2	NMOD	-1
4	chronic	chronic	B-NP	JJ	O	6	NMOD	-1
5	nonhealing	nonhealing	I-NP	JJ	O	6	NMOD	-1
6	wounds	wound	I-NP	NNS	O	3	PMOD	-1
7	which	which	B-NP	WDT	O	2	NMOD	-1
8	did	do	B-VP	VBD	O	7	SBAR	-1
9	not	not	I-VP	RB	O	8	VMOD	-1
10	respond	respond	I-VP	VB	O	8	VC	0
11	to	to	B-PP	TO	O	10	VMOD	-1
12	treatment	treatment	B-NP	NN	O	11	PMOD	0
13	for	for	B-PP	IN	O	10	VMOD	-1
14	at	at	B-NP	IN	O	17	NMOD	-1
15	least	least	I-NP	JJS	O	14	AMOD	-1
16	3	3	I-NP	CD	O	14	AMOD	-1
17	months	month	I-NP	NNS	O	13	PMOD	-1
18	were	be	B-VP	VBD	O	0	ROOT	-1
19	treated	treat	I-VP	VBN	O	18	VC	0
20	by	by	B-PP	IN	O	19	VMOD	-1
21	HBO	HBO	B-NP	NNP	B-protein	20	PMOD	-1
22	.	.	O	.	O	18	P	-1

1	All	All	B-NP	DT	O	2	SUB	-1
2	had	have	B-VP	VBD	O	0	ROOT	-1
3	palpable	palpable	B-NP	JJ	O	5	NMOD	-1
4	pedal	pedal	I-NP	JJ	O	5	NMOD	-1
5	pulses	pulse	I-NP	NNS	O	2	OBJ	-1
6	.	.	O	.	O	2	P	-1

1	Transcutaneous	Transcutaneous	B-NP	JJ	O	2	NMOD	-1
2	measurements	measurement	I-NP	NNS	O	6	SUB	-1
3	of	of	B-PP	IN	O	2	NMOD	-1
4	tissue	tissue	B-NP	NN	O	5	NMOD	-1
5	pO2	pO2	I-NP	NN	O	3	PMOD	-1
6	showed	show	B-VP	VBD	O	0	ROOT	-1
7	elevation	elevation	B-NP	NN	O	6	OBJ	0
8	from	from	B-PP	IN	O	7	NMOD	-1
9	20	20	B-NP	CD	O	11	AMOD	-1
10	+/-	+/-	I-NP	SYM	O	11	AMOD	-1
11	10	10	I-NP	CD	O	12	AMOD	-1
12	mm	mm	I-NP	NN	O	13	NMOD	-1
13	Hg	Hg	I-NP	NN	O	8	PMOD	-1
14	during	during	B-PP	IN	O	6	VMOD	-1
15	air	air	B-NP	NN	O	16	NMOD	-1
16	breathing	breathing	I-NP	NN	O	14	PMOD	-1
17	to	to	B-PP	TO	O	16	NMOD	-1
18	643	643	B-NP	CD	O	20	AMOD	-1
19	+/-	+/-	I-NP	SYM	O	20	AMOD	-1
20	242	242	I-NP	CD	O	22	NMOD	-1
21	mm	mm	I-NP	NN	O	20	AMOD	-1
22	Hg	Hg	I-NP	NN	O	17	PMOD	-1
23	while	while	B-SBAR	IN	O	6	VMOD	-1
24	breathing	breathe	B-VP	VBG	O	23	SBAR	-1
25	pure	pure	B-NP	JJ	O	26	NMOD	-1
26	oxygen	oxygen	I-NP	NN	O	24	OBJ	-1
27	at	at	B-PP	IN	O	24	VMOD	-1
28	2.5	2.5	B-NP	CD	O	29	NMOD	-1
29	ATA	ATA	I-NP	NN	O	27	PMOD	-1
30	.	.	O	.	O	6	P	-1

1	They	They	B-NP	PRP	O	2	SUB	-1
2	were	be	B-VP	VBD	O	0	ROOT	-1
3	treated	treat	I-VP	VBN	O	2	VC	0
4	with	with	B-PP	IN	O	3	VMOD	-1
5	HBO	HBO	B-NP	NN	B-protein	4	PMOD	-1
6	in	in	B-PP	IN	O	3	VMOD	-1
7	56	56	B-NP	CD	O	9	AMOD	-1
8	+/-	+/-	I-NP	SYM	O	9	AMOD	-1
9	10	10	I-NP	CD	O	12	NMOD	-1
10	consecutive	consecutive	I-NP	JJ	O	12	NMOD	-1
11	HBO	HBO	I-NP	NNP	O	12	NMOD	-1
12	sessions	session	I-NP	NNS	O	6	PMOD	-1
13	.	.	O	.	O	2	P	-1

1	In	In	B-PP	IN	O	4	VMOD	-1
2	11	11	B-NP	CD	O	1	PMOD	-1
3	there	there	B-NP	EX	O	4	SUB	-1
4	was	be	B-VP	VBD	O	0	ROOT	-1
5	complete	complete	B-NP	JJ	O	7	NMOD	-1
6	wound	wound	I-NP	NN	O	7	NMOD	-1
7	healing	healing	I-NP	NN	O	4	PRD	-1
8	,	,	O	,	O	4	P	-1
9	while	while	B-SBAR	IN	O	4	VMOD	-1
10	in	in	B-PP	IN	O	13	VMOD	-1
11	1	1	B-NP	CD	O	10	PMOD	-1
12	there	there	B-NP	EX	O	13	SUB	-1
13	was	be	B-VP	VBD	O	9	SBAR	-1
14	partial	partial	B-NP	JJ	O	15	NMOD	-1
15	response	response	I-NP	NN	O	13	PRD	0
16	,	,	O	,	O	13	P	-1
17	in	in	B-PP	IN	O	13	VMOD	-1
18	1	1	B-NP	CD	O	20	NMOD	-1
19	minimal	minimal	I-NP	JJ	O	20	NMOD	-1
20	response	response	I-NP	NN	O	17	PMOD	0
21	,	,	O	,	O	9	P	-1
22	and	and	O	CC	O	9	DEP	-1
23	in	in	B-PP	IN	O	22	DEP	-1
24	1	1	B-NP	CD	O	23	PMOD	-1
25	a	a	B-NP	DT	O	27	NMOD	-1
26	transient	transient	I-NP	JJ	O	27	NMOD	-1
27	response	response	I-NP	NN	O	23	PMOD	0
28	.	.	O	.	O	4	P	-1

1	HBO	HBO	B-NP	NNP	B-protein	2	SUB	-1
2	is	be	B-VP	VBZ	O	0	ROOT	-1
3	useful	useful	B-ADJP	JJ	O	2	PRD	-1
4	in	in	B-PP	IN	O	3	AMOD	-1
5	chronic	chronic	B-NP	JJ	O	7	NMOD	-1
6	nonhealing	nonhealing	I-NP	JJ	O	7	NMOD	-1
7	wounds	wound	I-NP	NNS	O	4	PMOD	-1
8	of	of	B-PP	IN	O	7	NMOD	-1
9	the	the	B-NP	DT	O	11	NMOD	-1
10	diabetic	diabetic	I-NP	JJ	O	11	NMOD	-1
11	foot	foot	I-NP	NN	O	8	PMOD	-1
12	and	and	B-PP	CC	O	4	PMOD	-1
13	of	of	B-PP	IN	O	4	PMOD	-1
14	the	the	B-NP	DT	O	16	NMOD	-1
15	diabetic	diabetic	I-NP	JJ	O	16	NMOD	-1
16	foot	foot	I-NP	NN	O	13	PMOD	-1
17	with	with	B-PP	IN	O	3	AMOD	-1
18	impending	impend	B-VP	VBG	O	17	PMOD	-1
19	amputation	amputation	B-NP	NN	O	18	OBJ	19	amputation
20	.	.	O	.	O	2	P	-1

1	It	It	B-NP	PRP	O	2	SUB	-1
2	is	be	B-VP	VBZ	O	12	VMOD	-1
3	a	a	B-NP	DT	O	5	NMOD	-1
4	safe	safe	I-NP	JJ	O	5	NMOD	-1
5	mode	mode	I-NP	NN	O	2	PRD	-1
6	of	of	B-PP	IN	O	5	NMOD	-1
7	therapy	therapy	B-NP	NN	O	6	PMOD	0
8	,	,	O	,	O	12	P	-1
9	but	but	O	CC	O	12	VMOD	-1
10	further	further	B-NP	JJ	O	11	NMOD	-1
11	studies	study	I-NP	NNS	O	12	SUB	-1
12	are	be	B-VP	VBP	O	0	ROOT	-1
13	required	require	I-VP	VBN	O	12	VC	0
14	to	to	I-VP	TO	O	15	VMOD	-1
15	establish	establish	I-VP	VB	O	12	VMOD	-1
16	its	its	B-NP	PRP$	O	17	NMOD	-1
17	efficacy	efficacy	I-NP	NN	O	15	OBJ	0
18	and	and	O	CC	O	12	VMOD	-1
19	to	to	B-VP	TO	O	20	VMOD	-1
20	ascertain	ascertain	I-VP	VB	O	12	VMOD	-1
21	which	which	B-NP	WDT	O	20	VMOD	-1
22	diabetic	diabetic	B-NP	JJ	O	21	NMOD	-1
23	patients	patient	I-NP	NNS	O	21	NMOD	-1
24	and	and	I-NP	CC	O	21	NMOD	-1
25	wounds	wound	I-NP	NNS	O	21	NMOD	-1
26	will	will	B-VP	MD	O	21	SBAR	-1
27	benefit	benefit	I-VP	VB	O	26	VC	-1
28	the	the	B-NP	DT	O	29	NMOD	-1
29	most	most	I-NP	JJS	O	27	OBJ	-1
30	from	from	B-PP	IN	O	29	NMOD	-1
31	it	it	B-NP	PRP	O	30	PMOD	-1
32	.	.	O	.	O	12	P	-1

